Clinical Trials Sponsored by Leadiant Biosciences Ltd.

Total 388 results

Prothena Biosciences Ltd.

Terminated

Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis (OLE)

AL Amyloidosis

United States
Prothena Biosciences Ltd.

Completed

The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis (PRONTO)

AL Amyloidosis

United States, Spain, Australia, Germany, United Kingdom, France, Greece, Israel, Italy, Austria
Clexio Biosciences Ltd.

Recruiting

A Study of CLE-400 (Topical Gel) for the Treatment of Chronic Pruritus in Adult Subjects With Notalgia Paresthetica

Chronic Pruritus in Adult Subjects With Notalgia Paresthetica (NP)

United States
Chipscreen Biosciences, Ltd.

Recruiting

A Study of CS23546 in Subjects With Advanced Tumors

Advanced Tumors

China
Chipscreen Biosciences, Ltd.

Not yet recruiting

A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic Profiles and Food Effect of CS32582 Capsules

Healthy

China
Modern Biosciences Ltd

Recruiting

A Study to Investigate Leramistat in Patients With IPF

Idiopathic Pulmonary Fibrosis

United States, United Kingdom, Israel, France, Germany, Greece, Hungary, Italy, Spain
Chimagen Biosciences, Ltd

Recruiting

First-in-Human (FIH) Trial of 1A46 in Subjects With Advanced CD20 and/or CD19 Positive B-cell Hematologic Malignancies

Non-Hodgkin's Lymphoma (Disorder) | Acute Lymphoid Leukemia, Disease (Disorder)

United States
Chipscreen Biosciences, Ltd.

Recruiting

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC. (SCLC)

Small Cell Lung Cancer | Advanced Solid Malignant Tumor

United States
Chipscreen Biosciences, Ltd.

Recruiting

Chiauranib Plus Weekly Paclitaxel in Patients With Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer (CHIPRO)

Ovarian Cancer | Relapsed or Refractory | Chiauranib | Paclitaxel

China
Chipscreen Biosciences, Ltd.

Recruiting

Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer

Small Cell Lung Cancer

China
Chipscreen Biosciences, Ltd.

Completed

A Phase II Clinical Trial of Chiglitazar for NASH

NASH

China
Prothena Biosciences Ltd.

Terminated

The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis (VITAL)

Primary Systemic (AL) Amyloidosis

United States, Spain, Israel, Canada, Poland, Netherlands, France, Germany, United Kingdom, Belgium, Denmark, Greece, Australia, Austria, Italy
Chipscreen Biosciences, Ltd.

Completed

Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects.

T2DM

China
Chipscreen Biosciences, Ltd.

Completed

Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma

Non-hodgkin's Lymphoma

China
Chipscreen Biosciences, Ltd.

Completed

Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Liminal BioSciences Ltd.

Terminated

Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome

Alström Syndrome

United Kingdom
Chipscreen Biosciences, Ltd.

Completed

Phase Ib Study of Chiauranib in Patients With Ovarian Cancer

Ovarian Cancer

China
Modern Biosciences Ltd

Completed

Safety, Tolerability and Efficacy of MBS2320 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Georgia, Moldova, Republic of, Romania
Liminal BioSciences Ltd.

Completed

Safety and Tolerability of PBI-4050 and Its Effects on the Biomarkers in Subjects With Alström Syndrome

Diabetes | Inflammation and Fibrosis

United Kingdom
Prothena Biosciences Ltd.

Completed

Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

Primary Amyloidosis

United States
Liminal BioSciences Ltd.

Completed

Study to Evaluate the Safety and Tolerability of PBI-4050 in Type 2 Diabetes Patients With Metabolic Syndrome

Metabolic Syndrome | Type 2 Diabetes

Canada
PeriTec Biosciences Ltd.

Unknown

Pilot Study to Evaluate the Safety and Preliminary Efficacy of the Peritec Peritoneal Lined Stent and Delivery System

Vascular Disease, Peripheral

Chile
Zomagen Biosciences, Ltd

Completed

A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome (Explore)

Cryopyrin Associated Periodic Syndrome

United States
University of Utah
Abbott; Leadiant Biosciences, Inc.; Families of Spinal Muscular Atrophy

Completed

Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patients With Spinal Muscular Atrophy

Spinal Muscular Atrophy

United States
University of Utah
Abbott; Leadiant Biosciences, Inc.; Families of Spinal Muscular Atrophy

Completed

Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy

Spinal Muscular Atrophy

United States, Canada
Vedic Lifesciences Pvt. Ltd.
Leading Edge Marketing LTD.

Completed

To Access the Effect of Brain Pill™ on Working Memory Capacity and Mood Behaviour.

Mood Disorders | Memory Dysfunction

India
SinoMab BioScience Ltd

Recruiting

A Phase 1 Study of Single and Multiple Intravenous Doses of SM17 in Healthy Subjects

1. Asthma

United States
SinoMab BioScience Ltd

Unknown

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Health Subject

Autoimmune Diseases

Australia
Fruitura Bioscience Ltd.

Completed

Effect of Red Grape Cells (RGC) Powder Consumption on Measures of Aerobic Fitness and Mood

Healthy

Israel
Ardana Bioscience Ltd

Completed

Study of 3 Doses of ARD-0403 in Testosterone Deficient Men (ARD-0403-001)

Hypogonadism

Belarus
SinoMab BioScience Ltd

Completed

A Study to Evaluate the Safety and Efficacy of SM03 in Patients With Rheumatoid Arthritis Receiving Methotrexate

Rheumatoid Arthritis

China
Fruitura Bioscience Ltd.

Completed

Pharmacokinetics of Resveratrol Comprising Products

Healthy

Israel
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.; Sciwind Biosciences USA Co., Ltd.

Recruiting

XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults

Obesity | Type 2 Diabetes Mellitus

Australia
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.; Sciwind Biosciences USA Co., Ltd.

Withdrawn

Safety and Efficacy of Inhaled XW001 For Hospitalized COVID-19 Patients Requiring Oxygen Therapy

COVID-19 Acute Respiratory Distress Syndrome

Argentina, Peru
SinoMab BioScience Ltd

Recruiting

A Study Assessing the Efficacy and Safety of SM03 in Patients With Active Rheumatoid Arthritis Receiving MTX

Rheumatoid Arthritis(RA)

China
SinoMab BioScience Ltd

Completed

A Study of the Pharmacokinetics and Safety of SM03 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

China
Ardana Bioscience Ltd

Completed

Open-Label Study of ARD-0403 in Testosterone Deficient Men

Hypogonadism

United States
Ardana Bioscience Ltd

Terminated

Open-Label Study of ARD-0403 in Testosterone Deficient Men (ARD-0403-010)

Hypogonadism

United States
Liminal BioSciences Ltd.
Celerion

Completed

Effect of PBI-4050 on the Pharmacokinetics of Midazolam in Heathy Adult Subjects

Healthy

United States
Atmo Biosciences Pty Ltd

Recruiting

Feasibility of a New Diagnostic Device to Assess Small Intestinal Dysbiosis in Routine Clinical Setting.

Small Intestinal Bacterial Overgrowth

Australia, India
Children's Mercy Hospital Kansas City
Leadiant Biosciences, Inc.; Minimed Pharmaceuticals; Pharmacia/Upjohn Career...

Completed

Carnitine Levels and Carnitine Supplementation in Type I Diabetes

Hypoglycemia | Diabetes Mellitus, Type I

United States
Akeso
Chipscreen Biosciences, Ltd.

Active, not recruiting

A Study of AK104 in Combination With Chiauranib in Patients With Extensive Stage Small Cell Lung Cancer

SCLC,Extensive Stage

Australia, China
Atmo Biosciences Pty Ltd

Active, not recruiting

Comparison of the Atmo Motility Gas Capsule System to the Reference Standard

Gastroparesis | IBS | Slow Transit Constipation

United States
Modern Biosciences Ltd
Covance

Completed

Safety and Tolerability Study of MBS2320 in Healthy Subjects and Subjects With Rheumatoid Arthritis

Arthritis, Rheumatoid

United Kingdom
Enzene Biosciences Ltd.
Alkem Laboratories Ltd

Recruiting

Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers

Healthy Male Subjects

Bulgaria, Poland
Enzene Biosciences Ltd.
Alkem Laboratories Ltd

Recruiting

A Phase 3 Study to Compare Biosimilar Denosumab With Prolia®

Postmenopausal Osteoporosis

Czechia
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.

Completed

To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants (XW003)

Obesity | Type 2 Diabetes Mellitus | Nonalcoholic Steatohepatitis

Australia
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.

Completed

Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity

Obesity

Australia
TopAlliance Biosciences
Shanghai Junshi Bioscience Co., Ltd.; CTI Clinical Trial and Consulting Services

Recruiting

Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies

Metastatic Solid Tumor | Advanced Unresectable Solid Tumor

United States
Lin BioScience, Inc
Lin BioScience Pty Ltd

Recruiting

The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias

Relapsed or Resistant Acute Leukaemias

Taiwan, Australia

Clinical Trials Sponsored by Leadiant Biosciences Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations